Yu Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
Papers in
- Immunology 77
- Immunotherapy and Immune Responses 34
- Immune Cell Function and Interaction 16
- Immune cells in cancer 15
-
- MicroRNA in disease regulation 36
- Cancer-related molecular mechanisms research 14
- Co-authors
- Lixia WangYanlin ZhaoDaniel P. ChinShengfen WangGuangxue HeYou‐Wen HeHongtao ZhangJing Guo
- Journals
- PLoS ONE (8 papers)Frontiers in Pharmacology (6 papers)Blood (5 papers)Scientific Reports (5 papers)Frontiers in Immunology (4 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yu Wang
232 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 1.2k
- Infectious Diseases 1.3k
- Immunology 1.0k
- Epidemiology 1.6k
- Hepatology 323
Countries citing papers authored by Yu Wang
This map shows the geographic impact of Yu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wang more than expected).
Fields of papers citing papers by Yu Wang
This network shows the impact of papers produced by Yu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wang. The network helps show where Yu Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 17 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 21 | |
| 15 | 2019 | 20 | |
| 16 | 2019 | 77 | |
| 17 | 2018 | 33 | |
| 18 | 2017 | 51 | |
| 19 | 2013 | 26 | |
| 20 | 2010 | 29 |
About Yu Wang
Yu Wang is a scholar working on Immunology, Cancer Research, Epidemiology, Molecular Biology and Oncology, having authored 247 papers that have together received 5.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (36 papers), Immunotherapy and Immune Responses (34 papers), Hepatitis B Virus Studies (17 papers), RNA Interference and Gene Delivery (16 papers), Immune Cell Function and Interaction (16 papers), Immune cells in cancer (15 papers), Cancer-related molecular mechanisms research (14 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Cancer Research (1.2k citations), Infectious Diseases (1.3k citations), Immunology (1.0k citations), Epidemiology (1.6k citations) and Hepatology (323 citations). Yu Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lixia Wang, Yanlin Zhao, Daniel P. Chin, Shengfen Wang, Guangxue He, You‐Wen He, Hongtao Zhang, Jing Guo, Yu Pang and Qiang Li. Their work appears in journals such as PLoS ONE, Frontiers in Pharmacology, Blood, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.